Business Description
Naturewise Biotech & Medicals Corp
NAICS : 325411
SIC : 2833
ISIN : TW0004732003
Description
Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 58.59 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.31 | |||||
| Interest Coverage | 92.81 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 14.38 | |||||
| Beneish M-Score | -3.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19.8 | |||||
| 3-Year EBITDA Growth Rate | -34.4 | |||||
| 3-Year EPS without NRI Growth Rate | -46.7 | |||||
| 3-Year FCF Growth Rate | 3.9 | |||||
| 3-Year Book Growth Rate | 1.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.38 | |||||
| 9-Day RSI | 55.78 | |||||
| 14-Day RSI | 56.88 | |||||
| 6-1 Month Momentum % | -6.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.46 | |||||
| Quick Ratio | 11.07 | |||||
| Cash Ratio | 9.77 | |||||
| Days Inventory | 241.31 | |||||
| Days Sales Outstanding | 39.62 | |||||
| Days Payable | 25.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.7 | |||||
| Dividend Payout Ratio | 1.61 | |||||
| Forward Dividend Yield % | 0.7 | |||||
| 5-Year Yield-on-Cost % | 0.7 | |||||
| Shareholder Yield % | 0.38 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 54.92 | |||||
| Operating Margin % | 3.55 | |||||
| Net Margin % | 7.02 | |||||
| FCF Margin % | 22.36 | |||||
| ROE % | 2.5 | |||||
| ROA % | 2.27 | |||||
| ROIC % | 4.27 | |||||
| ROC (Joel Greenblatt) % | 25.72 | |||||
| ROCE % | 2.55 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 92.46 | |||||
| PE Ratio without NRI | 92.46 | |||||
| Price-to-Owner-Earnings | 23.97 | |||||
| PS Ratio | 6.34 | |||||
| PB Ratio | 2.21 | |||||
| Price-to-Tangible-Book | 2.34 | |||||
| Price-to-Free-Cash-Flow | 28.41 | |||||
| Price-to-Operating-Cash-Flow | 28.08 | |||||
| EV-to-EBIT | 56.41 | |||||
| EV-to-EBITDA | 34.11 | |||||
| EV-to-Revenue | 4.12 | |||||
| EV-to-FCF | 18.37 | |||||
| Price-to-Projected-FCF | 2.16 | |||||
| Price-to-Median-PS-Value | 1.23 | |||||
| Price-to-Graham-Number | 3.1 | |||||
| Price-to-Net-Current-Asset-Value | 2.49 | |||||
| Price-to-Net-Cash | 3.27 | |||||
| Earnings Yield (Greenblatt) % | 1.77 | |||||
| FCF Yield % | 3.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Naturewise Biotech & Medicals Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 224.575 | ||
| EPS (TTM) (NT$) | 0.272 | ||
| Beta | 1.42 | ||
| Volatility % | 24.72 | ||
| 14-Day RSI | 56.88 | ||
| 14-Day ATR (NT$) | 0.692497 | ||
| 20-Day SMA (NT$) | 25.02 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 20.56042 - 26.1 | ||
| Shares Outstanding (Mil) | 56.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Naturewise Biotech & Medicals Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Naturewise Biotech & Medicals Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Naturewise Biotech & Medicals Corp Frequently Asked Questions
What is Naturewise Biotech & Medicals Corp(ROCO:4732)'s stock price today?
The current price of ROCO:4732 is NT$25.15. The 52 week high of ROCO:4732 is NT$26.10 and 52 week low is NT$20.56.
When is next earnings date of Naturewise Biotech & Medicals Corp(ROCO:4732)?
The next earnings date of Naturewise Biotech & Medicals Corp(ROCO:4732) is .
Does Naturewise Biotech & Medicals Corp(ROCO:4732) pay dividends? If so, how much?
The Dividend Yield %  of Naturewise Biotech & Medicals Corp(ROCO:4732) is 0.7% (As of Today), Highest Dividend Payout Ratio of Naturewise Biotech & Medicals Corp(ROCO:4732) was 2.49. The lowest was 0.16. And the median was 0.49. The  Forward Dividend Yield % of Naturewise Biotech & Medicals Corp(ROCO:4732) is 0.7%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers